Antiviral agents 1
A meeting was held on Wednesday, 15 April 1981, on the subject of antiviral agents. The first contributor was Dr A J Beale, who spoke on the control of virus infections. He began by pointing out that there were three basic methods for controlling virus diseases. These were sanitary measures, vaccines and chemotherapeutic antiviral agents. These three separate approaches to the control of virus diseases were discussed in relation to numerous examples, and it was pointed out that sonie were more applicable to certain infections than others. Under certain circumstances more than one method may be combined together. Endemic or exotic diseases present different problems. Sanitary and hygienic methods, including quarantine, had been successful in the control of many major diseases. Rapid and accurate diagnosis of the condition using both clinical and laboratory facilities was necessary for success in this field. Examples quoted included foot and mouth disease and rabies. Vaccination had been extremely successful in the control of certain diseases. For example, the world was declared free of smallpox on 8 May 1980. The possibility of eradicating diseases such as poliomyelitis and measles through the use of vaccines was discussed. So far as antiviral agents were concerned, we were still in the very early days. The broadest spectrum antiviral agent found so far is interferon. It is a naturally-produced substance active against most species of virus. It is, of course, animal species specific.
Interferon, classified into alpha, beta and gamma types, was discussed. The major problem with interferon is a production problem. Recombinant DNA technology is now being developed to produce interferon, but at present large quantities can be obtained from lymphoblastoid cells which can be grown in large scale fermentation vessels. The efficacy of interferon has been widely investigated using animal models. In man it has been used successfully to treat virus infections, especially herpes simplex and varicella zoster in immunosuppressed patients. It has also shown promise in some tumours, notably osteogenic sarcoma, but no controlled trials in cancer had been completed.
The second contributor, Dr G Appleyard, spoke on the role of antiviral agents in man. He began by considering which viruses most require chemotherapy. The list of candidate viruses has, of course, changed over the years dependingon the I Report of meeting of Section of Comparative Medicine, \5 April \98\ 0141-0768/81/080628-02/$01.00 success of other control methods such as the use of vaccines. Infections which do not lend themselves to control by this method, such as respiratory tract infection, would be very good candidates for the use of antiviral agents. This would include influenza viruses as well as corona viruses and other respiratory infections. Herpes viruses, which are widespread in man, can cause very serious clinical disease and the effect of such infections is made worse by immunosuppressive drugs.
At the present time there are only four licensed antiviral agents available in Great Britain. These were discussed in detail. Amantadine acts early in the growth cycle of virus, but a precise mechanism for its action is not known. Its antiviral activity is fairly specific, for example, influenza A is sensitive but influenza B is resistant. In one clinical trial in the USA the use of Amantadine reduced illness from influenza A from 20.1% to 5.9%. That was a prophylactic use before exposure; therapeutic use has reduced the severity of disease if given within 24 to 48 hours but has no effect if applied later. IUDR (2-deoxy-5-iodouridine) is an agent which stops RNA synthesis. It is an effective drug for the treatment of herpetic keratitis, but is too toxic for systemic use where it will cause bone marrow depression and thrombocytopenia. Cytarabine is a cytotoxic drug introduced for the treatment of herpes simplex and varicella zoster but in control trials has been found to be ineffective. Adenine arabinoside (or Vidarabine) has advantages because it can be given systemically. Its use has produced better results than IUDR in the treatment of herpes keratitis and in controlled studies in the USA has produced beneficial effects in early cases of herpes encephalitis. A new substance which has just been licensed for ophthalmic use is Acyclovir. It is phosphorylated by a herpes virus coded thymidine kinase in infected cells, and subsequently converted to the triphosphate by cellular enzymes. The end product inhibits viral DNA polymerase. It is of low toxicity. In clinical trials in man this agent showed beneficial effects in the treatment of herpes keratitis superior to those seen with other drugs. It is also effective in the treatment of herpes simplex in immunosuppressed patients.
The final contribution was given by Mr G White, who spoke on the role of antiviral agents in animals other than man. He began by pointing out that at the present time antiviral agents are not being' used in the treatment of animal diseases, although they are used in animal model systems. There is a great potential for their use in veterinary medicine, but it is not yet possible to speak of © \98\ The Royal Society of Medicine Journal of the Royal Society of Medicine Volume 74 August 1981 629 current applications. It was necessary to consider carefully the size of the potential market for such agents for treatment of animal diseases and to analyse the cost of developing drugs for use in animals, especially tests for drug residues in animals used for food. The need for safety testing of drugs of this type and the complications of requiring withdrawal periods from animals were discussed. Milk and eggs pose a particular problem since they must be free of very low levels of residue. Numerous virus diseases of domesticated animals were discussed, and each was considered in relation to the possibility that antiviral agents could in future be useful for prophylaxis or therapy. Because of the success in (November 1980Journal. p 786) . He commented that the effects of drugs such as pethidine on neurobehavioural scores of neonates had been the subject of considerable research; and there has been much speculation on the possibility of changes persisting into childhood. This has caused concern among those responsible for providing pain relief during childbirth. He also noted that the slightly lower scores for children delivered by elective as opposed to emergency section might cause a 'reaction against caesarean section which is safer to the mother for both the anaesthetic and obstetric considerations. ' We have re-analysed our data to investigate these points.
Letters to the Editor
Methods of pain relief were categorized as follows: (1) general anaesthesia; (2) epidural (or caudal); (3) analgesia only (usually pethidine); (4) none. They were coded in order of priority. Thus, many women who had general anaesthetics or epidurals may have received pethidine earlier. Local anaesthetics were considered of less importance than pethidine, and when used alone (or in association with the gas and air machine) were included in the 'none' category. the human field, it was likely that infection of cattle with herpes viruses might be treated with antiviral agents. Work had been carried out on infectious bovine rhinotracheitis and on mammilitis in cattle. Work was in progress on treating orf with antiviral agents.
The meeting as a whole gave a comprehensive overview of antiviral agents and their stage of development in clinical medicine in the human and veterinary fields. Each contribution was followed by a livelydiscussion which indicated considerable interest in the subject of the meeting.
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Strong associations were found between method of pain relief and method of delivery. All the caesarean sections were done under a general anaesthetic; and in addition 5 women were examined under general anaesthesia prior to vaginal delivery. Among those delivered spontaneously 14% had no pain relief, 68% had pethidine alone, and 18% epidurals. The epidural rate associated with forceps deliveries was 70%. Among vaginal deliveries no significant differences were found in the developmental status of the children at the age of 4 years according to methods of pain relief used during childbirth. The mean scores were: none 49.3 s.d. 12.4; pethidine 49.7 s.d. 10.9; epidural 47,4 s.d, 10.6. The actual dosage of pethidine, or number of injections given, was not coded. But if further relief was needed after the effects of one dose had worn off, resort was usually made to epidural anaesthesia. The slightly lower score found in the latter group should not therefore be taken as indicating any direct effect. .
In a separate study (Ounsted et al. 1978) , the , neurological status of babies born to primiparous women was assessed on days one and five and again at the age of two months. On each occasion a standardized examination was used for which a score could be given. Among 50 women who laboured spontaneously no significant differences were found according to method of pain relief during labour at any of these assessments. The mean values at the age of two months were: none
